SURGICAL INNOVATIONS GROUP PLC

Regulatory Filings • Mar 18, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1791A

Surgical Innovations Group PLC

18 March 2013

Surgical Innovations Group plc

("SI" or the "Company")

Change of Advisor

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of creative solutions for minimally invasive surgery ('MIS'), is pleased to announce that Panmure Gordon (UK) Limited has been appointed as the Company's nominated adviser and broker with immediate effect.

- ENDS -

Enquiries:

Surgical Innovations Group plc		www.sigroupplc.com
Doug Liversidge, Non-Executive Chairman	Tel: +44 (0) 113 230 7597
Graham Bowland, Chief Executive Officer	graham.bowland@surginno.co.uk
Panmure Gordon (Nominated Advisor & Broker)			www.panmure.com
Freddy Crossley (Corporate Finance)	Tel: +44 (0) 20 7886 2500
Adam Pollock/ Victoria Boxall (Corporate Broking)
Walbrook PR Ltd	Tel: +44 (0) 20 7933 8780
Paul McManus	Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com
Lianne Cawthorne	Mob: 07584 391 303 or lianne.cawthorne@walbrookpr.com

Notes to Editors:

About Surgical Innovations Group plc

Surgical Innovations Group plc specialises in the design and manufacture of creative solutions for minimally invasive surgery (MIS) and industrial markets. 

As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.

Over 120 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.

The Group's patented products are sold through three main channels:

SI brand	Through an established network of distribution partners, Surgical Innovations branded products are sold in major medical markets including North America, Britain, South East Asia, Australasia and the Indian subcontinent.
OEM and IP	The Group supplies large medical device companies on an OEM basis, generating both sales and IP royalty fees.  Clients include Teleflex Medical, Olympus and CareFusion.
Industrial	SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, in situ with minimum disassembly and downtime.

For more information, see www.sigrouplplc.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

APPFMGMFNKDGFZM